Protagonist Therapeutics Inc buy Truist Financial Co.
Start price
10.08.26
/
50%
€130.00
Target price
10.08.27
€147.14
Performance (%)
0.00%
Price
10.08.26
€130.00
Summary
This prediction is currently active. Truist_Financial_Co_'s BUY prediction for Protagonist Therapeutics Inc is currently unchanged. This prediction currently runs until 10.08.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Protagonist Therapeutics Inc | 0.00% |
| iShares Core DAX® | 1.001% |
| iShares Nasdaq 100 | 2.702% |
| iShares Nikkei 225® | 3.519% |
| iShares S&P 500 | 1.766% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) was given a new $170.00 price target by Truist Financial Corporation. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€66.00
28.10.25
28.10.25
€75.49
28.10.26
28.10.26
96.97%
10.08.26
10.08.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
11.03.25
11.03.25
€70.01
11.03.26
11.03.26
66.34%
12.03.26
12.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
09.09.24
09.09.24
€54.34
09.09.25
09.09.25
4.95%
10.09.25
10.09.25